28 related articles for article (PubMed ID: 33120314)
1. Why are older women not having surgery for breast cancer? A qualitative study.
Sowerbutts AM; Griffiths J; Todd C; Lavelle K
Psychooncology; 2015 Sep; 24(9):1036-42. PubMed ID: 25645068
[TBL] [Abstract][Full Text] [Related]
2. Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life.
Wyld L; Reed MWR; Morgan J; Collins K; Ward S; Holmes GR; Bradburn M; Walters S; Burton M; Herbert E; Lifford K; Edwards A; Ring A; Robinson T; Martin C; Chater T; Pemberton K; Shrestha A; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter M; Naik J; Parmeshwar R; Patnick J; Gosney M; Hatton M; Thomson AM
Eur J Cancer; 2021 Jan; 142():48-62. PubMed ID: 33220653
[TBL] [Abstract][Full Text] [Related]
3. Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer.
Tamirisa N; Lin H; Shen Y; Shaitelman SF; Sri Karuturi M; Giordano SH; Babiera G; Bedrosian I
JAMA Oncol; 2020 Oct; 6(10):1548-1554. PubMed ID: 32672820
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis.
Yuan C; Xie Z; Bian J; Huo J; Daily K
Breast Cancer Res Treat; 2020 Apr; 180(3):819-827. PubMed ID: 32172303
[TBL] [Abstract][Full Text] [Related]
5. Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women.
Nayyar A; Strassle PD; Iles K; Jameison D; Jadi J; McGuire KP; Gallagher KK
Ann Surg Oncol; 2020 Nov; 27(12):4853-4860. PubMed ID: 32918178
[TBL] [Abstract][Full Text] [Related]
6. Matched case-control survival analysis of older chinese breast cancer patients treated with surgery or primary endocrine therapy.
Suen TD; Luk WP; Fung LH; Kwong A
Cancer Treat Res Commun; 2020; 25():100227. PubMed ID: 33120314
[TBL] [Abstract][Full Text] [Related]
7. The role of primary endocrine therapy in older women with operable breast cancer.
Johnston SJ; Cheung KL
Future Oncol; 2015; 11(10):1555-65. PubMed ID: 25963432
[TBL] [Abstract][Full Text] [Related]
8. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
Hind D; Wyld L; Beverley CB; Reed MW
Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480
[TBL] [Abstract][Full Text] [Related]
9. Preoperative endocrine therapy for older women with breast cancer: renewed interest in an old idea.
Ellis MJ
Cancer Control; 2000; 7(6):557-62. PubMed ID: 11088064
[TBL] [Abstract][Full Text] [Related]
10. The primary use of endocrine therapies.
Howell A; Anderson E; Blamey R; Clarke RB; Dixon JM; Dowsett M; Johnston SR; Miller WR; Nicholson R; Robertson JF
Recent Results Cancer Res; 1998; 152():227-44. PubMed ID: 9928561
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Gibson LJ; Dawson C; Lawrence DH; Bliss JM
Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
